Skip to content
Recall Observatory FDA recall evidence

Drug product

Suprax (cefixime for oral suspension) USP, 100 mg/5 mL, 50 mL bottles (when reconstituted), Manufactured for Lupin Pharmaceuticals, Inc. 111 South Calvert Street, Baltimore, MD 21202, Manufactured by Lupin Limited Mumbai 400 058 India, NDC 68180-202-03.

D-264-2013

January 31, 2013

Class III

Product summary

Firm
Lupin Pharmaceuticals Inc.
Event
Event 64325
Status
Terminated
Classification
Class III
Quantity
64,368 bottles
Official record key
drug-enforcement:D-264-2013

Official wording

Reason: Discoloration; Product may not meet specifications for color description once reconstituted.

Code information: Lot #s: MSA 2021A, MSA 2024A, MSA 2025A, Exp July 2014

Distribution pattern: Nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    may not meet specifications